The impact of structured self-monitoring of blood glucose on glycaemic variability in non-insulin treated type 2 diabetes: The SMBG study, a 12-month randomised controlled trial.
There is inconsistent evidence supporting the self-monitoring of blood glucose (SMBG) in people...
Read More